Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150639 · ClinicalTrials.gov registry record
Vaginal Microbiome and IVF Pregnancy Outcome
A clinical trial of Vaginal Flora Imbalance, sponsored by Freya Biosciences ApS.
- Completed
- Registry status
- 301
- Enrollment target
- 1
- Study location
NCT05150639 is a study of Vaginal Flora Imbalance that has completed, run by Freya Biosciences ApS. The registered enrollment target is 301 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05150639, a study of Vaginal Flora Imbalance, has completed, sponsored by Freya Biosciences ApS.
- COMPLETED
- Registry status
- 301 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this prospective, observational study is to investigate the prevalence of vaginal dysbiosis among women undergoing IVF procedures in the US. And to investigate the associations between the vaginal microbiome and the pregnancy outcome following IVF.
Conditions Studied
Interventions
- OTHER IVF
Study Locations (1)
Massachusetts
- Boston IVF The Waltham Center - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2022-03-18 |
| Est. Completion | 2023-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05150639
The ClinicalTrials.gov registry entry for NCT05150639 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Freya Biosciences ApS, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaginal Flora Imbalance appearing as the primary indexed condition, and to 1 intervention - of which IVF is the first listed.
NCT05150639 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05150639 about?
NCT05150639 is a clinical study titled "Vaginal Microbiome and IVF Pregnancy Outcome". The aim of this prospective, observational study is to investigate the prevalence of vaginal dysbiosis among women undergoing IVF procedures in the US. And to investigate the associations between the vaginal microbiome and the pregnancy outcome following IVF.
What is the current status of trial NCT05150639?
This trial is currently completed. The enrollment target is 301 participants. The study started on 2022-03-18. Estimated completion is 2023-05-26.
What conditions does trial NCT05150639 study?
This clinical trial studies the following conditions: Vaginal Flora Imbalance.
What interventions are being tested in trial NCT05150639?
The interventions under investigation include: IVF (OTHER).
Who is sponsoring clinical trial NCT05150639?
This trial is sponsored by Freya Biosciences ApS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05150639 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.